Psyadon Pharma: Clinical Trials

7 trials sponsored by Psyadon Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated. 4 Phase 1, 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 23Completed 3
Phase 31Terminated 1

Follow Psyadon Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam - Tourette's Syndrome
Phase 2CompletedEmalex Biosciences Inc.402014-06-192026-05-22
Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
Ecopipam, Placebo - Lesch-Nyhan Disease, Self-injurious Behavior
Phase 3TerminatedEmalex Biosciences Inc.92012-12-012024-04-22
Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam
Ecopipam immediate release form, 90 mg controlled release form, 180 mg controlled release form - Healthy
Phase 1CompletedEmalex Biosciences Inc.162011-08-012024-04-19
Ecopipam Treatment of Tourette Syndrome
Ecopipam - Tourette's Syndrome
Phase 1 / Phase 2CompletedPsyadon Pharma182010-10-012015-09-29
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
Ecopipam - Pathological Gambling
Phase 2CompletedEmalex Biosciences Inc.342010-10-012024-05-14
Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease
Ecopipam - Lesch-Nyhan Disease
Phase 1CompletedPsyadon Pharma52010-02-012013-04-18
Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue
Thiamphenicol, Placebo - Healthy
Phase 1CompletedPsyadon Pharma302007-07-012015-03-25

Conditions studied

Lesch-Nyhan Syndrome (2)  ·  Self-Injurious Behavior (2)  ·  Tourette Syndrome (2)  ·  Gambling (1)

Interventions

ecopipam (6)  ·  Thiamphenicol (1)

Countries

United States (6)  ·  Belgium (1)  ·  Spain (1)

Top investigators

Donald Gilbert, MD (2)  ·  Donald Black, MD (1)  ·  H J Jinnah, MD (1)  ·  Hyder A Jinnah, MD (1)  ·  Jon Grant, MD (1)  ·  Marc Potenza, MD (1)  ·  Mohamed Al-Ibrahim, MB,ChB,FACP (1)  ·  Richard E Chipokin, PhD (1)  ·  Timothy Fong, MD (1)  ·  William L Nyhan, MD (1)

Results publications

PMID 25166480, PMID 30192018